All Relations between Depression and neurotransmitter

Publication Sentence Publish Date Extraction Date Species
L H Price, D S Charney, A L Rubin, G R Heninge. Alpha 2-adrenergic receptor function in depression. The cortisol response to yohimbine. Archives of general psychiatry. vol 43. issue 9. 1986-10-02. PMID:3019271. there is evidence that the abnormalities in hypothalamic-pituitary-adrenal (hpa) axis function observed in patients with depression may be related to changes in central neurotransmitter receptor function. 1986-10-02 2023-08-11 Not clear
H A Menkes, J M Baraban, A N Freed, S H Snyde. Lithium dampens neurotransmitter response in smooth muscle: relevance to action in affective illness. Proceedings of the National Academy of Sciences of the United States of America. vol 83. issue 15. 1986-09-17. PMID:2874555. dampening of neurotransmitter responses by lithium treatment may explain the unique ability of lithium to relieve and prevent both mania and depression. 1986-09-17 2023-08-11 Not clear
G M Hasey, H C Stancer, J J Warsh, E Persa. Neurotransmitter metabolites and endocrine responses in depression. Progress in neuro-psychopharmacology & biological psychiatry. vol 9. issue 5-6. 1986-03-18. PMID:2418468. neurotransmitter metabolites and endocrine responses in depression. 1986-03-18 2023-08-11 human
L Brodin, S Grillne. The role of putative excitatory amino acid neurotransmitters in the initiation of locomotion in the lamprey spinal cord. I. The effects of excitatory amino acid antagonists. Brain research. vol 360. issue 1-2. 1986-02-14. PMID:2866822. the mode and time course of the depression (by excitatory amino acid antagonists) of fictive locomotion, induced by sensory stimulation, shows that the putative excitatory amino acid neurotransmitter directly or indirectly acts at the pattern generating circuitry within the spinal cord. 1986-02-14 2023-08-11 Not clear
W F Byerley, S C Risc. Depression and serotonin metabolism: rationale for neurotransmitter precursor treatment. Journal of clinical psychopharmacology. vol 5. issue 4. 1985-09-19. PMID:2410463. depression and serotonin metabolism: rationale for neurotransmitter precursor treatment. 1985-09-19 2023-08-11 Not clear
K J Gingrich, J H Byrn. Simulation of synaptic depression, posttetanic potentiation, and presynaptic facilitation of synaptic potentials from sensory neurons mediating gill-withdrawal reflex in Aplysia. Journal of neurophysiology. vol 53. issue 3. 1985-05-23. PMID:2580065. the model not only simulates the data of synaptic depression and recovery from depression, but also qualitatively predicts other features of neurotransmitter release that it was not designed to fit. 1985-05-23 2023-08-11 aplysia
K J Gingrich, J H Byrn. Simulation of synaptic depression, posttetanic potentiation, and presynaptic facilitation of synaptic potentials from sensory neurons mediating gill-withdrawal reflex in Aplysia. Journal of neurophysiology. vol 53. issue 3. 1985-05-23. PMID:2580065. rather a large component of synaptic depression is due to reduction to the pools of releasable neurotransmitter (depletion). 1985-05-23 2023-08-11 aplysia
B E Leonar. Neurotransmitter markers of depression. The Australian and New Zealand journal of psychiatry. vol 18. issue 4. 1985-03-06. PMID:6151835. neurotransmitter markers of depression. 1985-03-06 2023-08-12 Not clear
M V Rudorfer, F Karoum, R J Ross, W Z Potter, M Linnoil. Differences in lithium effects in depressed and healthy subjects. Clinical pharmacology and therapeutics. vol 37. issue 1. 1985-02-21. PMID:2578106. our and other studies suggest that li has a corrective action in patients with depression and hypothesized neurotransmitter abnormalities, but li does not affect individuals without affective disorders. 1985-02-21 2023-08-11 human
D C Jimerso. Neurotransmitter hypotheses of depression. Research update. The Psychiatric clinics of North America. vol 7. issue 3. 1984-11-21. PMID:6207513. neurotransmitter hypotheses of depression. 1984-11-21 2023-08-12 Not clear
D C Jimerso. Neurotransmitter hypotheses of depression. Research update. The Psychiatric clinics of North America. vol 7. issue 3. 1984-11-21. PMID:6207513. recent research on the amine neurotransmitter hypotheses of depression has moved toward comparative analysis of presynaptic neurotransmitter release and postsynaptic receptor function. 1984-11-21 2023-08-12 Not clear
J D Raine. Genetic factors in depression and suicide. American journal of psychotherapy. vol 38. issue 3. 1984-11-05. PMID:6207737. biological studies involving neurotransmitter levels suggest that suicide even without depression may be uniquely characterized, and there have been reports of associated brain-wave dysfunction. 1984-11-05 2023-08-12 Not clear
S M Stah. Regulation of neurotransmitter receptors by desipramine and other antidepressant drugs: the neurotransmitter receptor hypothesis of antidepressant action. The Journal of clinical psychiatry. vol 45. issue 10 Pt 2. 1984-11-01. PMID:6090439. recent findings on neurotransmitter receptors are reviewed as they relate to current hypotheses of the etiology of depression and mechanism of action of antidepressant drugs. 1984-11-01 2023-08-12 Not clear
J Ong, D I Ker. Interactions between GABA and 5-hydroxytryptamine in the guinea-pig ileum. European journal of pharmacology. vol 94. issue 3-4. 1984-02-14. PMID:6317404. it is concluded that the early, short-lived depression is mediated through gabaa-receptor sites, and the delayed, longer-lasting depression through gabab-receptor sites on neurones of the myenteric plexus; effects consistent with gaba being a neurotransmitter in the enteric nervous system. 1984-02-14 2023-08-12 Not clear
M It. Evidence for synaptic plasticity in the cerebellar cortex. Acta morphologica Hungarica. vol 31. issue 1-3. 1983-11-23. PMID:6312772. a similar long-lasting depression was shown to occurred in sensitivity of purkinje cell dendrites to a putative neurotransmitter of parallel fibers, i.e., glutamate. 1983-11-23 2023-08-12 Not clear
D L Murphy, R M Cohen, L J Siever, B Roy, F Karoum, R J Wyatt, N A Garrick, M Linnoil. Clinical and laboratory studies with selective monoamine-oxidase-inhibiting drugs. Implications for hypothesized neurotransmitter changes associated with depression and antidepressant drug effects. Modern problems of pharmacopsychiatry. vol 19. 1983-08-11. PMID:6408411. implications for hypothesized neurotransmitter changes associated with depression and antidepressant drug effects. 1983-08-11 2023-08-12 Not clear
Y D Lapierr. Neurotransmitter functions in depression. Progress in neuro-psychopharmacology & biological psychiatry. vol 6. issue 4-6. 1983-04-07. PMID:6187047. neurotransmitter functions in depression. 1983-04-07 2023-08-12 Not clear
J W Phillis, P H W. Adenosine mediates sedative action of various centrally active drugs. Medical hypotheses. vol 9. issue 4. 1983-03-11. PMID:6130465. the primary mode of action of adenosine in exerting this action appears to be the depression of calcium entry, thus decreasing presynaptic neurotransmitter release. 1983-03-11 2023-08-12 Not clear
H Beckman. Recent concepts of neuromodulators in affective disorders. L'Encephale. vol 8. issue 2. 1982-10-21. PMID:6125377. as antidepressants have differential influence on neurotransmitter function and prediction of clinical response is unreliable, recent investigations attempt to define more "serotoninergic" or "noradrenergic" types of endogenous depression. 1982-10-21 2023-08-12 human
M Ito, M Sakurai, P Tongroac. Climbing fibre induced depression of both mossy fibre responsiveness and glutamate sensitivity of cerebellar Purkinje cells. The Journal of physiology. vol 324. 1982-09-24. PMID:7097592. these observations suggest that subsynaptic chemosensitivity of purkinje cells to the putative neurotransmitter of parallel fibres is involved in the depression observed after conjunctive stimulation of a vestibular nerve and the inferior olive.6. 1982-09-24 2023-08-12 Not clear